Tocqueville Asset Management L.P. Buys Shares of 5,478 VanEck Biotech ETF (NASDAQ:BBH)

Tocqueville Asset Management L.P. purchased a new position in VanEck Biotech ETF (NASDAQ:BBH) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 5,478 shares of the company’s stock, valued at approximately $860,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Kovitz Investment Group Partners LLC raised its holdings in VanEck Biotech ETF by 4.6% in the third quarter. Kovitz Investment Group Partners LLC now owns 3,186 shares of the company’s stock worth $565,000 after buying an additional 141 shares during the last quarter. Farther Finance Advisors LLC bought a new stake in shares of VanEck Biotech ETF during the fourth quarter valued at approximately $32,000. Flagship Harbor Advisors LLC increased its position in shares of VanEck Biotech ETF by 12.1% during the fourth quarter. Flagship Harbor Advisors LLC now owns 1,984 shares of the company’s stock valued at $311,000 after acquiring an additional 214 shares in the last quarter. Truvestments Capital LLC purchased a new position in VanEck Biotech ETF in the 3rd quarter worth approximately $44,000. Finally, FSA Wealth Management LLC bought a new position in VanEck Biotech ETF in the 3rd quarter valued at approximately $54,000. Hedge funds and other institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Trading Down 0.1 %

VanEck Biotech ETF stock opened at $162.46 on Thursday. VanEck Biotech ETF has a 12 month low of $151.35 and a 12 month high of $183.64. The stock has a fifty day simple moving average of $162.86 and a two-hundred day simple moving average of $167.38. The firm has a market cap of $396.40 million, a price-to-earnings ratio of 33.67 and a beta of 0.85.

VanEck Biotech ETF Dividend Announcement

The business also recently announced a dividend, which was paid on Tuesday, December 24th. Shareholders of record on Monday, December 23rd were paid a dividend of $1.2517 per share. The ex-dividend date of this dividend was Monday, December 23rd.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.